Correction to: Oncogene (2015) 34, 3188–3198; doi:10.1038/onc.2015.129; published online 20 April 2015
Post publication the author realised that some of the supplementary information had been incorrectly labelled. The supplementary files have been corrected online and the corrected paper appears in this issue.
The authors would like to apologise for this error.
Additional information
The online version of the original article can be found at 10.1038/onc.2015.129
Rights and permissions
About this article
Cite this article
Lei, ZJ., Wang, J., Xiao, HL. et al. Erratum: Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of β-catenin signaling. Oncogene 34, 3214 (2015). https://doi.org/10.1038/onc.2015.182
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2015.182
This article is cited by
-
Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation
Cell Death Discovery (2023)
-
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Journal of Biomedical Science (2021)
-
Delta-like 4/Notch signaling promotes Apc Min/+ tumor initiation through angiogenic and non-angiogenic related mechanisms
BMC Cancer (2017)
-
Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer
Scientific Reports (2017)